Envista Stock (NYSE:NVST)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$24.50

52W Range

$18.25 - $30.42

50D Avg

$25.08

200D Avg

$23.38

Market Cap

$4.00B

Avg Vol (3M)

$2.96M

Beta

0.89

Div Yield

-

NVST Company Profile


Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.

Show More

Industry

Medical - Equipment & Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

12,300

IPO Date

Sep 18, 2019

Website

NVST Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 24Dec 23Dec 22
Specialty Products and Technologies$1.62B$1.64B-
Equipment and Consumables$894.20M$924.10M-
Equipment Sales--$421.60M
Consumables--$2.15B

Fiscal year ends in Dec 25 | Currency in USD

NVST Financial Summary


Dec 25Dec 24Dec 23
Revenue$2.72B$2.51B$2.57B
Operating Income$225.70M$-1.04B$31.50M
Net Income$47.00M$-1.12B$-100.20M
EBITDA$341.70M$279.50M$463.00M
Basic EPS$0.28$-6.50$-0.60
Diluted EPS$0.28$-6.50$-0.60

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 06, 26 | 12:00 AM
Q4 25Feb 06, 26 | 5:00 PM
Q3 25Oct 31, 25 | 5:00 PM

Peer Comparison


TickerCompany
GRALGRAIL, Inc.
ICUIICU Medical, Inc.
SUPNSupernus Pharmaceuticals, Inc.
RAREUltragenyx Pharmaceutical Inc.
PRVAPrivia Health Group, Inc.
ALHCAlignment Healthcare, Inc.
XRAYDENTSPLY SIRONA Inc.
DYNDyne Therapeutics, Inc.
CONConcentra Group Holdings Parent, Inc.
APGEApogee Therapeutics, Inc.